1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cephalosporin Market, By Generation
5.1 Introduction
5.2 First-generation Cephalosporin
5.3 Second-generation Cephalosporin
5.4 Third-generation Cephalosporin
5.5 Fourth-generation Cephalosporin
5.6 Fifth-generation Cephalosporin
6 Global Cephalosporin Market, By Type
6.1 Introduction
6.2 Branded
6.3 Generic
7 Global Cephalosporin Market, By Route of Administration
7.1 Introduction
7.2 Intravenous
7.3 Oral
8 Global Cephalosporin Market, By Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacy
8.3 Retail Pharmacy
8.4 Online Pharmacy
9 Global Cephalosporin Market, By Dosage Form
9.1 Introduction
9.2 Capsules
9.3 Tablets
9.4 Other Dosage Forms
10 Global Cephalosporin Market, By Application
10.1 Introduction
10.2 Respiratory Tract Infection
10.3 Ear Infection
10.4 Sexually Transmitted Infection
10.5 Skin Infection
10.6 Urinary Tract Infection
10.7 Other Applications
11 Global Cephalosporin Market, By End User
11.1 Introduction
11.2 Hospitals
11.3 Specialty Clinics
11.4 Homecare
11.5 Other End Users
12 Global Cephalosporin Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 Key Developments
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 Company Profiling
14.1 F. Hoffmann-La Roche Ltd.
14.2 Teva Pharmaceutical Industries Ltd.
14.3 Mylan N.V.
14.4 Pfizer Inc.
14.5 Novartis AG
14.6 GlaxoSmithKline plc
14.7 Merck & Co., Inc.
14.8 AstraZeneca
14.9 Aurobindo Pharma
14.10 Johnson & Johnson Private Limited
14.11 Cipla Inc.
14.12 Sun Pharmaceutical Industries Ltd.
14.13 Currax Pharmaceuticals LLC
14.14 Novo Nordisk A/S
14.15 Takeda Pharmaceutical Company Limited
14.16 Aristo Pharmaceuticals Ltd
14.17 Baxter International
14.18 Lupin Pharmaceuticals Inc.
14.19 Mankind Pharma
14.20 Macleods Pharmaceuticals Ltd
List of Tables
Table 1 Global Cephalosporin Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Cephalosporin Market Outlook, By Generation (2021-2030) ($MN)
Table 3 Global Cephalosporin Market Outlook, By First-generation Cephalosporin (2021-2030) ($MN)
Table 4 Global Cephalosporin Market Outlook, By Second-generation Cephalosporin (2021-2030) ($MN)
Table 5 Global Cephalosporin Market Outlook, By Third-generation Cephalosporin (2021-2030) ($MN)
Table 6 Global Cephalosporin Market Outlook, By Fourth-generation Cephalosporin (2021-2030) ($MN)
Table 7 Global Cephalosporin Market Outlook, By Fifth-generation Cephalosporin (2021-2030) ($MN)
Table 8 Global Cephalosporin Market Outlook, By Type (2021-2030) ($MN)
Table 9 Global Cephalosporin Market Outlook, By Branded (2021-2030) ($MN)
Table 10 Global Cephalosporin Market Outlook, By Generic (2021-2030) ($MN)
Table 11 Global Cephalosporin Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 12 Global Cephalosporin Market Outlook, By Intravenous (2021-2030) ($MN)
Table 13 Global Cephalosporin Market Outlook, By Oral (2021-2030) ($MN)
Table 14 Global Cephalosporin Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 15 Global Cephalosporin Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
Table 16 Global Cephalosporin Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
Table 17 Global Cephalosporin Market Outlook, By Online Pharmacy (2021-2030) ($MN)
Table 18 Global Cephalosporin Market Outlook, By Dosage Form (2021-2030) ($MN)
Table 19 Global Cephalosporin Market Outlook, By Capsules (2021-2030) ($MN)
Table 20 Global Cephalosporin Market Outlook, By Tablets (2021-2030) ($MN)
Table 21 Global Cephalosporin Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
Table 22 Global Cephalosporin Market Outlook, By Application (2021-2030) ($MN)
Table 23 Global Cephalosporin Market Outlook, By Respiratory Tract Infection (2021-2030) ($MN)
Table 24 Global Cephalosporin Market Outlook, By Ear Infection (2021-2030) ($MN)
Table 25 Global Cephalosporin Market Outlook, By Sexually Transmitted Infection (2021-2030) ($MN)
Table 26 Global Cephalosporin Market Outlook, By Skin Infection (2021-2030) ($MN)
Table 27 Global Cephalosporin Market Outlook, By Urinary Tract Infection (2021-2030) ($MN)
Table 28 Global Cephalosporin Market Outlook, By Other Applications (2021-2030) ($MN)
Table 29 Global Cephalosporin Market Outlook, By End User (2021-2030) ($MN)
Table 30 Global Cephalosporin Market Outlook, By Hospitals (2021-2030) ($MN)
Table 31 Global Cephalosporin Market Outlook, By Specialty Clinics (2021-2030) ($MN)
Table 32 Global Cephalosporin Market Outlook, By Homecare (2021-2030) ($MN)
Table 33 Global Cephalosporin Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
